These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 23370349)

  • 1. Novel insights into disease modeling using induced pluripotent stem cells.
    Egashira T; Yuasa S; Fukuda K
    Biol Pharm Bull; 2013; 36(2):182-8. PubMed ID: 23370349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human-induced pluripotent stem cells as models for rare cardiovascular diseases: from evidence-based medicine to precision medicine.
    Pan Z; Ebert A; Liang P
    Pflugers Arch; 2021 Jul; 473(7):1151-1165. PubMed ID: 33206225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induced Pluripotent Stem Cells in Disease Modeling and Gene Identification.
    Kumar S; Blangero J; Curran JE
    Methods Mol Biol; 2018; 1706():17-38. PubMed ID: 29423791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
    Liu Y; Deng W
    Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of induced pluripotent stem cells in lysosomal storage diseases.
    Kido J; Nakamura K; Era T
    Mol Cell Neurosci; 2020 Oct; 108():103540. PubMed ID: 32828964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular Disease Modeling Using Patient-Specific Induced Pluripotent Stem Cells.
    Tanaka A; Yuasa S; Node K; Fukuda K
    Int J Mol Sci; 2015 Aug; 16(8):18894-922. PubMed ID: 26274955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induced Pluripotent Stem Cells (iPSCs) in Developmental Toxicology.
    Easley CA
    Methods Mol Biol; 2019; 1965():19-34. PubMed ID: 31069666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New iPSC for old long QT syndrome modeling: putting the evidence into perspective.
    Li G; Cheng G; Wu J; Ma S; Sun C
    Exp Biol Med (Maywood); 2014 Feb; 239(2):131-40. PubMed ID: 24363251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling and Precision Medicine: A Scientific Statement From the American Heart Association.
    Musunuru K; Sheikh F; Gupta RM; Houser SR; Maher KO; Milan DJ; Terzic A; Wu JC;
    Circ Genom Precis Med; 2018 Jan; 11(1):e000043. PubMed ID: 29874173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translation of Human-Induced Pluripotent Stem Cells: From Clinical Trial in a Dish to Precision Medicine.
    Sayed N; Liu C; Wu JC
    J Am Coll Cardiol; 2016 May; 67(18):2161-2176. PubMed ID: 27151349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent progress of iPSC technology in cardiac diseases.
    Funakoshi S; Yoshida Y
    Arch Toxicol; 2021 Dec; 95(12):3633-3650. PubMed ID: 34657219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new era of disease modeling and drug discovery using induced pluripotent stem cells.
    Suh W
    Arch Pharm Res; 2017 Jan; 40(1):1-12. PubMed ID: 27921262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome Editing and Induced Pluripotent Stem Cell Technologies for Personalized Study of Cardiovascular Diseases.
    Chun YW; Durbin MD; Hong CC
    Curr Cardiol Rep; 2018 Apr; 20(6):38. PubMed ID: 29666931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is Human-induced Pluripotent Stem Cell the Best Optimal?
    Wang F; Kong J; Cui YY; Liu P; Wen JY
    Chin Med J (Engl); 2018 Apr; 131(7):852-856. PubMed ID: 29578130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe DCM phenotype of patient harboring RBM20 mutation S635A can be modeled by patient-specific induced pluripotent stem cell-derived cardiomyocytes.
    Streckfuss-Bömeke K; Tiburcy M; Fomin A; Luo X; Li W; Fischer C; Özcelik C; Perrot A; Sossalla S; Haas J; Vidal RO; Rebs S; Khadjeh S; Meder B; Bonn S; Linke WA; Zimmermann WH; Hasenfuss G; Guan K
    J Mol Cell Cardiol; 2017 Dec; 113():9-21. PubMed ID: 28941705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advancing drug discovery for neuropsychiatric disorders using patient-specific stem cell models.
    Haggarty SJ; Silva MC; Cross A; Brandon NJ; Perlis RH
    Mol Cell Neurosci; 2016 Jun; 73():104-15. PubMed ID: 26826498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling of hemophilia A using patient-specific induced pluripotent stem cells derived from urine cells.
    Jia B; Chen S; Zhao Z; Liu P; Cai J; Qin D; Du J; Wu C; Chen Q; Cai X; Zhang H; Yu Y; Pei D; Zhong M; Pan G
    Life Sci; 2014 Jul; 108(1):22-9. PubMed ID: 24834837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concise Review: Induced Pluripotent Stem Cell Research in the Era of Precision Medicine.
    Hamazaki T; El Rouby N; Fredette NC; Santostefano KE; Terada N
    Stem Cells; 2017 Mar; 35(3):545-550. PubMed ID: 28100040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease signatures for schizophrenia and bipolar disorder using patient-derived induced pluripotent stem cells.
    Watmuff B; Berkovitch SS; Huang JH; Iaconelli J; Toffel S; Karmacharya R
    Mol Cell Neurosci; 2016 Jun; 73():96-103. PubMed ID: 26777134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights into the genic and metabolic characteristics of induced pluripotent stem cells from polycystic ovary syndrome women.
    Min Z; Gao Q; Zhen X; Fan Y; Tan T; Li R; Zhao Y; Yu Y
    Stem Cell Res Ther; 2018 Aug; 9(1):210. PubMed ID: 30092830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.